Portfolio of Biotech Stocks

Here is a sample of 16 biotech stocks from the huge universe of biotechnology companies.

16 Biotech Stocks - I

Stock & Price Chart


Recent Prices &
Annualized Return

ACADIA PharmaceuticalsACAD
Acorda TherapeuticsACOR
Agios PharmaceuticalsAGIO
Alexion PharmaceuticalsALXN
Alnylam PharmaceuticalsALNY
Anika TherapeuticsANIK
Arrowhead ResearchARWR
BioCryst PharmaceuticalsBCRX
Biogen IdecBIIB
BioMarin PharmaceuticalBMRN
bluebird bioBLUE
Celgene CELG
Cell TherapeuticsCTIC
Price data from Quandl as of most recent close.

To inspect the performance of the Biotech Stocks - I portfolio, see the chart of portfolio below. Portfolio values are computed using monthly closes for stocks from Quandl.

The 14 stocks included in the portfolio computations are: ACAD, ACOR, AGEN, ALXN, ALKS, ALNY, AMGN, ANIK, ARWR, BCRX, BIIB, BMRN, CELG and CTIC. The current value of the portfolio assumes that $714.29 was invested (total of $10,000) in each stock at its closing monthly price for the current date in 2009. All prices are adjusted for splits and dividends. AGIO and BLUE were excluded from the portfolio computations because of insufficient price data.

The current value of a $10,000 investment is $65,562. The percent return is 555.62%. The annualized return is 20.69%.

NOTE: The stocks included in the table and chart are representative of the industry. They are not recommendations.

Related Portfolios

Portfolio of Biotech Stocks: Diabetes

Portfolio of Dividend-Paying Pharmaceutical Stocks

Portfolio of Stem Cell Stocks